T1 mapping and major cardiovascular events in non-ischaemic dilated cardiomyopathy: a systematic review and

Federico Marchini1, Beatrice Dal Passo1, Gianluca Campo1

  • 1Cardiovascular Institute, Azienda Ospedaliero Universitaria di Ferrara, Ferrara, Italy.

ESC Heart Failure
|April 26, 2025
PubMed

Insights

Native T1 mapping and extracellular volume (ECV) predict major adverse cardiovascular events (MACE) in non-ischaemic dilated cardiomyopathy (NIDCM) patients. These cardiac MRI techniques identify patients at higher risk for heart failure and arrhythmias.

Area of Science:

  • Cardiology
  • Radiology
  • Medical Imaging

Background:

  • Non-ischaemic dilated cardiomyopathy (NIDCM) is a significant cause of heart failure.
  • Accurate risk stratification is crucial for managing NIDCM patients.
  • T1 mapping techniques offer novel insights into myocardial tissue characterization.

Purpose of the Study:

  • To evaluate the prognostic value of T1 mapping and extracellular volume (ECV) in predicting major adverse cardiovascular events (MACE) in NIDCM.
  • To conduct a meta-analysis of existing studies to consolidate evidence.

Main Methods:

  • A meta-analysis of 12 observational studies involving 4025 NIDCM patients.
  • Analysis of native T1 mapping and ECV for prediction of MACE, heart failure, and arrhythmic events.
  • Random effects model with generic inverse variance for pooled hazard ratios (HR) and mean differences.

Main Results:

  • Native T1 mapping showed a pooled HR of 1.07 (95% CI 1.04-1.09) for MACE.
  • ECV demonstrated a pooled HR of 1.37 (95% CI 1.29-1.44) for MACE.
  • Both T1 mapping and ECV were significantly associated with increased risk of MACE, heart failure, and arrhythmic events.

Conclusions:

  • Native T1 mapping and ECV are valuable prognostic markers in NIDCM.
  • These cardiac MRI techniques can identify patients at elevated risk for adverse cardiovascular outcomes.
  • Integration of T1 mapping and ECV into clinical practice may improve NIDCM patient management.
Abstract

Related Concept Videos

Imaging Studies for Cardiovascular System IV: CMRI01:21

Imaging Studies for Cardiovascular System IV: CMRI

Cardiovascular magnetic resonance imaging, or CMRI, is a non-invasive diagnostic test that employs a magnetic field and radiofrequency waves to create precise images of the heart and arteries. It provides comprehensive information about cardiac anatomy, function, perfusion, and tissue characterization without ionizing radiation.IndicationsCMRI diagnoses various heart conditions, including tissue damage from heart attacks, ischemic heart disease, myocarditis, aortic issues (tears, aneurysms,...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...